# Sino Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sino-health

- Industry: Healthcare
- Headquarters: Shanghai, China
- Latest round: Series A (Dec 4, 2015)
- Investors on record: 1

## About

Founded in 2018 in Shanghai, Sino Health has built a specialty care pharmaceutical platform targeting the Chinese market. It has expanded operations with regional offices in Beijing, Guangzhou, Chengdu, and Shenzhen. In January 2022, Nuance Biotech acquires Sino Health to further strengthen its commercial capabilities and expand pipelines. The company focuses on the in-licensing, development, and commercialization of specialty pharmaceutical products in Greater China. Therapeutic areas of focus include iron deficiency anemia, post-operative pain management, and respiratory conditions. Sino Health generates revenue through commercialization of licensed pharmaceuticals, clinical development services, and strategic partnerships in the specialty care segment. The company plans to expand its portfolio of in-licensed products, deepen commercial penetration in key therapeutic areas, and enhance its presence across the Greater China and broader Asia-Pacific markets.

## Funding rounds

- Series A, Dec 4, 2015 — Frontline BioVentures

## Investors

- Frontline BioVentures (https://capitalatlas.ai/funds/frontline-bioventures) — Series A